EAGLE PHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q4 2014 to Q2 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Eagle Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q4 2014 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Current Ratio for the quarter ending June 30, 2023 was 181 %, a 22.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 181 -53.1 -22.7% Jun 30, 2023
Q1 2023 173 -109 -38.7% Mar 31, 2023
Q4 2022 182 -144 -44.2% Dec 31, 2022
Q3 2022 195 -196 -50.2% Sep 30, 2022
Q2 2022 234 -160 -40.6% Jun 30, 2022
Q1 2022 282 -116 -29.2% Mar 31, 2022
Q4 2021 326 +39.8 +13.9% Dec 31, 2021
Q3 2021 391 +100 +34.5% Sep 30, 2021
Q2 2021 393 +93 +31% Jun 30, 2021
Q1 2021 399 +105 +35.5% Mar 31, 2021
Q4 2020 287 -124 -30.2% Dec 31, 2020
Q3 2020 291 -109 -27.2% Sep 30, 2020
Q2 2020 300 -126 -29.6% Jun 30, 2020
Q1 2020 294 -152 -34.1% Mar 31, 2020
Q4 2019 410 -72.4 -15% Dec 31, 2019
Q3 2019 400 -75.7 -15.9% Sep 30, 2019
Q2 2019 426 -42.1 -8.99% Jun 30, 2019
Q1 2019 446 -19.7 -4.23% Mar 31, 2019
Q4 2018 483 +68.2 +16.4% Dec 31, 2018
Q3 2018 475 +98 +26% Sep 30, 2018
Q2 2018 469 +138 +41.7% Jun 30, 2018
Q1 2018 466 +136 +41.2% Mar 31, 2018
Q4 2017 415 +80.4 +24% Dec 31, 2017
Q3 2017 377 +17 +4.71% Sep 30, 2017
Q2 2017 331 -32.9 -9.05% Jun 30, 2017
Q1 2017 330 -54.3 -14.1% Mar 31, 2017
Q4 2016 334 -74.8 -18.3% Dec 31, 2016
Q3 2016 360 -27.4 -7.06% Sep 30, 2016
Q2 2016 364 -11.5 -3.06% Jun 30, 2016
Q1 2016 384 +46 +13.6% Mar 31, 2016
Q4 2015 409 +122 +42.5% Dec 31, 2015
Q3 2015 388 Sep 30, 2015
Q2 2015 375 Jun 30, 2015
Q1 2015 338 Mar 31, 2015
Q4 2014 287 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.